Abstract Lichenicolous fungus LL-RB0668 was isolated from a processed lichen thallus on a modified Lilly-Barnett solid medium. Two new bisnaphthopyrone compounds, lichenicolins A (1) and B (2), were isolated from the culture broth of this organism fermented on a rice-based solid medium. These results demonstrate that lichenassociated fungi potentially are a good resource for new bioactive natural products for current screening programs.
region of nuclear ribosomal DNA obtained from this fungus did not reveal close matches with any entries in the GenBank ® database.
Fermentation
Fungal culture LL-RB0668 was plated on Difco potatodextrose agar from a frozen 25% glycerol stock culture and then incubated at 22°C. A small agar slice bearing mycelial growth was used to inoculate 50 ml of seed culture in Difco potato dextrose broth in a 250-ml Erlenmeyer flask shaken at 200 rpm at 22°C for one week. Scaled-up fermentations were performed in 2.8-liter Fernbach flasks containing 102 g milled rice and 88 ml of a 0.1% yeast -extract solution per flask. A total of 3 solid-medium cultures were inoculated with seed and maintained static at 22°C for 2 weeks.
Compound Purification
After the fermentation was completed, the cultures were lyophilized and extracted with methanol (3 liters 
Results and Discussion
The lichenicolous fungus, LL-RB0668, was fermented on a solid medium for two weeks. Purification of the methanol extract of the fermentation medium yielded two new metabolites, designated lichenicolins A and B (Fig. 1) . The structure of lichenicolin A was elucidated on the basis of detailed spectroscopic analysis to be bisnaphthopyrone 1 and the structure of lichenicolin B was proposed as 2 by comparison of its NMR data with those of 1 and luteosporin (6) .
The molecular formula of lichenicolin A (1) was determined by high resolution Fourier transform ion cyclotron resonance (FTICR) mass spectrometry to be C 34 H 30 O 12 . The initial analysis of the 13 C NMR spectral data in DMSO-d 6 indicated the presence of 17 carbon signals, which only accounted for half of the carbons required by the molecular formula. Therefore, compound 1 most likely possessed a symmetric dimer structure. The UV spectrum of 1 was consistent with that of a 3,4-dihydro-9,10-dihydroxy-7-methoxy-naphtho[2,3-c]pyran-1-one moiety (termed "naphthopyrone"), similar to those contained in compounds semivioxanthin (3) [8, 9] and vioxanthin (4) [10] . C NMR spectral data (Table 1 ) assigned by direct C-H correlations in an HSQC spectrum and multiple bond correlations in an HMBC spectrum confirmed the presence of the naphthopyrone moiety. The H-6 at d 7.02 showed strong correlations ( 3 J CH ) to C-5, -8, and -9a, and weaker correlations ( 2 J CH or 4 J CH ) to C-7 and -9 in the HMBC spectrum. The H-5 at d 7.37 on the other hand displayed strong correlations ( 3 J CH ) to C-4, -6, -9a, and -10a, and weaker correlations ( 2 J CH or 4 J CH ) to C-1, -4a, -5a, -9, and -10. The 13 C NMR chemical shift data of the carbonyl and the aromatic carbons in 1 were almost identical to those in semivioxanthin (3), except that the methine C-8 signal at d 99.1 in 3 [8] was replaced by a quaternary carbon signal at 109.02 in 1. The nature of C-8 was indicative of an 8,8Ј-linkage between the two halves of the molecule in compound 1. As supporting evidence, the nOes between the H-5 and H-6, and between H-6 and methoxyl group, observed in a ROESY spectrum, excluded the possibility of a 6,6Ј-linkage (Fig. 2) . Both the 8,8Ј-and 6,6Ј-bisnaphthopyrones were previously reported as antibacterial compounds, which could respectively be represented by fungal metabolites, vioxanthin (4) and SC-28763 (5) [11, 12] . Unlike in 3 and 4, the C-4 in compound 1 was an oxygen-attached methine. In a COSY spectrum, the H-4 signal at d 5.02 was correlated to the methine signal H-3 at 5.39, which was in turn correlated to the 13-methylene signals at 2.53 and 2.06. These two signals were further coupled to H-12 at d 4.37, which was then coupled to the 14-methyl signal at 1.29. The molecular formula required that each half-molecule contain an additional ring system to fuse to the naphthopyrone moiety. An HMBC correlation between H-12 at d 4.37 and C-4 at 72.63 indicated the presence of an ether bridge between C-4 and C-12, which gave rise to a substituted furan ring. In a ROESY spectrum, nuclear Overhauser effects (nOes) were observed between the H-3 and H-4 signals, and between the H-4 and 14-methyl signals (Table 1) , which defined a cis ring junction between the furan and a -pyrone, and synfacial configuration between H-4 and 14-methyl. The relative stereochemistry of compound 1 and the selected nOes are shown in Fig. 2 . The tetracycle system as described in 1 has not been reported in literature.
The molecular formula of lichenicolin B (2) was 734 a Not observed due to small quantity. b The cause of double peaks has not been experimentally studied. However, it could be attributed to the presence of diastereomers due to hindered rotation about the Ar-ArЈ bond. determined by FTICR mass spectrometry to be C 33 H 26 O 13 . The UV spectrum of 2 showed an absorption shoulder at ϳ440 nm, which tailed the naphthopyrone absorption maximum at 376 nm. Both the 1 H and 13 C NMR spectra indicated that 2 was an asymmetric dimer, with half of the molecule being identical to the naphthopyrone monomer in 1 ( Table 2) . On the basis of 13 C NMR signals at d 187.32 (C-6), 159.47 (C-8), and 180.75 (C-9), and the molecular formula, an hydroxyquinone moiety was proposed for the other half of compound 2. This moiety was found in luteosporin (6) [13] , a phospholipase A 2 inhibitor isolated from Penicillium chermesinum. The aromatic carbon signals of 2 were comparable to those reported for 6 (differences Ͻ2 ppm) with the exception of C-4a (Table 2) .
Lichenicolin A (1) showed moderate to good activity against Gram-positive bacteria, including strains of methicillin-resistant Staphylococcus areus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). For Gram-negative bacteria, compound 1 showed activity against Escherichia coli but no activity against Pseudomonas aeruginosa. Compound 1 was also inactive against the yeast Candida albicans. Interestingly, lichenicolin A (1) was far less active against E. coli widetype strain (#442) than the imp strain (#389, strain with increased outer membrane permeability), suggesting poor permeability across the normal Gram-negative outer membrane. Lichenicolin B (2), on the other hand was inactive against all tested organisms. MIC data obtained by the broth dilution method [14] are listed in Table 3 .
In a recent publication, pigmentosin A (7), a bisnaphthopyrone compound, was described as a secondary metabolite from a foliose lichen Hypotrachyna immaculata [15] . It will be interesting to investigate whether this compound can be produced by a culturable fungus from H. immaculata.
In summary, lichenicolous fungus LL-RB0668 was isolated from a processed lichen thallus on a modified Lilly-Barnett solid medium containing L-ribitol. The major antimicrobial lichenicolins A (1) and the minor inactive lichenicolin B (2) were purified from the culture of this organism fermented on a rice-based solid medium. Results obtained from LL-RB0668 and other cultures we studied further demonstrate that lichen-associated fungi are a good resource for new bioactive natural products, and they deserve more attention from screening scientists. 
